We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR
Read MoreHide Full Article
For Immediate Release
Chicago, IL – January 11, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson (JNJ - Free Report) , Micron Technology, Inc. (MU - Free Report) , The Southern Company (SO - Free Report) , TotalEnergies SE (TTE - Free Report) and PACCAR Inc. (PCAR - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for Johnson & Johnson, Micron and Southern Company
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Micron Technology, Inc. and The Southern Company. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Johnson & Johnson have gained +3.4% over the past six months against the Zacks Large Cap Pharmaceuticals industry's gain of +17.3%. The company, due to the separation of the Consumer Health unit, has now become a two-sector company focused on the Innovative Medicine and MedTech fields.
Growth in the Innovative Medicine unit is being driven by existing products like Darzalex, Tremfya, Erleada, Invega Sustenna and Uptravi, and also continued uptake of new launches, including Spravato, Carvykti and Tecvayli. The MedTech unit is showing improving trends, driven by a recovery in surgical procedures and contribution from new products.
J&J is making rapid progress with its pipeline and line extensions. However, headwinds like generic competition and pricing pressure persist. Though J&J has taken meaningful steps to resolve its talc and opioid litigation, uncertainty exists regarding the talc litigations.
Micron Technology's shares were in line with the Zacks Semiconductor Memory industry over the past six months (+31.4% vs. +31.4%). The company's better-than-expected first-quarter performance, along with sequential growth across all key metrics, reflects the benefits of an improving supply-demand environment and signals that the industrywide sluggish period is nearing its end, and the company is moving back to profitability.
The expectation of supply normalization by mid-year 2024 is likely to drive pricing, while the boom in artificial intelligence spending is expected to fuel demand for its chips used in the data center end market. A rising mix of high-value solutions and improving customer engagement and cost structure are growth drivers as well.
Additionally, 5G adoption in the IoT devices and wireless infrastructure is likely to spur demand for memory and storage. However, the United States and China's tit-for-tat trade war is a major threat to the company.
Southern Company's shares have outperformed the Zacks Utility - Electric Power industry over the past six months (+3.7% vs. -4.7%). The company is leveraging the demographics of its operating territories, as in healthy population and job growth, the utility has gradually increased its customer base.
With good rate-base growth and constructive regulations, the power supplier is expected to generate steady earnings and dividend growth in the coming years. However, its elevated leverage, along with continued timing and cost overrun issues over its Vogtle project, are major overhangs.
While the electric utility holding company's debt-to-capitalization of 62.6% restricts financial flexibility, its $25-billion Vogtle nuclear plant has already exceeded budget and is years behind schedule. Therefore, Southern Company warrants a cautious stance for investors.
Other noteworthy reports we are featuring today are TotalEnergies SE and PACCAR Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR
For Immediate Release
Chicago, IL – January 11, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson (JNJ - Free Report) , Micron Technology, Inc. (MU - Free Report) , The Southern Company (SO - Free Report) , TotalEnergies SE (TTE - Free Report) and PACCAR Inc. (PCAR - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for Johnson & Johnson, Micron and Southern Company
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Micron Technology, Inc. and The Southern Company. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of Johnson & Johnson have gained +3.4% over the past six months against the Zacks Large Cap Pharmaceuticals industry's gain of +17.3%. The company, due to the separation of the Consumer Health unit, has now become a two-sector company focused on the Innovative Medicine and MedTech fields.
Growth in the Innovative Medicine unit is being driven by existing products like Darzalex, Tremfya, Erleada, Invega Sustenna and Uptravi, and also continued uptake of new launches, including Spravato, Carvykti and Tecvayli. The MedTech unit is showing improving trends, driven by a recovery in surgical procedures and contribution from new products.
J&J is making rapid progress with its pipeline and line extensions. However, headwinds like generic competition and pricing pressure persist. Though J&J has taken meaningful steps to resolve its talc and opioid litigation, uncertainty exists regarding the talc litigations.
(You can read the full research report on Johnson & Johnson here >>>)
Micron Technology's shares were in line with the Zacks Semiconductor Memory industry over the past six months (+31.4% vs. +31.4%). The company's better-than-expected first-quarter performance, along with sequential growth across all key metrics, reflects the benefits of an improving supply-demand environment and signals that the industrywide sluggish period is nearing its end, and the company is moving back to profitability.
The expectation of supply normalization by mid-year 2024 is likely to drive pricing, while the boom in artificial intelligence spending is expected to fuel demand for its chips used in the data center end market. A rising mix of high-value solutions and improving customer engagement and cost structure are growth drivers as well.
Additionally, 5G adoption in the IoT devices and wireless infrastructure is likely to spur demand for memory and storage. However, the United States and China's tit-for-tat trade war is a major threat to the company.
(You can read the full research report on Micron Technology here >>>)
Southern Company's shares have outperformed the Zacks Utility - Electric Power industry over the past six months (+3.7% vs. -4.7%). The company is leveraging the demographics of its operating territories, as in healthy population and job growth, the utility has gradually increased its customer base.
With good rate-base growth and constructive regulations, the power supplier is expected to generate steady earnings and dividend growth in the coming years. However, its elevated leverage, along with continued timing and cost overrun issues over its Vogtle project, are major overhangs.
While the electric utility holding company's debt-to-capitalization of 62.6% restricts financial flexibility, its $25-billion Vogtle nuclear plant has already exceeded budget and is years behind schedule. Therefore, Southern Company warrants a cautious stance for investors.
(You can read the full research report on Southern Company here >>>)
Other noteworthy reports we are featuring today are TotalEnergies SE and PACCAR Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.